Mark Ragosa Sells 1,123 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) CFO Mark Ragosa sold 1,123 shares of the firm’s stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $21.25, for a total value of $23,863.75. Following the transaction, the chief financial officer now directly owns 22,958 shares in the […]
More Stories
TD SYNNEX (NYSE:SNX) Stock Price Up 5.4% – Should You Buy?
Shares of TD SYNNEX Co. (NYSE:SNX – Get Free Report) were up 5.4% on Friday . The stock traded as...
Endeavour Silver (NYSE:EXK) Trading 6.2% Higher – Should You Buy?
Endeavour Silver Corp. (NYSE:EXK – Get Free Report) (TSE:EDR) shot up 6.2% during mid-day trading on Friday . The company...
LyondellBasell Industries (NYSE:LYB) Shares Purchased by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its holdings in LyondellBasell Industries (NYSE:LYB – Free Report) by 20.2% during the 4th quarter, according...
Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO) Shares Bought by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO – Free Report) by 98.5%...
Ridgewood Investments LLC Decreases Holdings in Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV)
Ridgewood Investments LLC trimmed its stake in shares of Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV – Free Report)...
Smith & Nephew plc (NYSE:SNN) Stock Position Lifted by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 6.1% during...